Attached files

file filename
EX-32 - EX-32 - NORTECH SYSTEMS INCa15-11900_1ex32.htm
EX-10.1 - EX-10.1 - NORTECH SYSTEMS INCa15-11900_1ex10d1.htm
EX-31.2 - EX-31.2 - NORTECH SYSTEMS INCa15-11900_1ex31d2.htm
EX-31.1 - EX-31.1 - NORTECH SYSTEMS INCa15-11900_1ex31d1.htm

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

(Mark One)

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2015

 

OR

 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from            to           

 

NORTECH SYSTEMS INCORPORATED

 

Commission file number 0-13257

 

State of Incorporation: Minnesota

 

IRS Employer Identification No. 41-1681094

 

Executive Offices: 7550 Meridian Circle N, Maple Grove, MN 55369

 

Former Name. Former Address and Former Fiscal Year, if Changed Since Last Report: 1120

Wayzata Blvd E., Suite 201, Wayzata, MN 55391

 

Telephone number: (952) 345-2244

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer o

 

Accelerated Filer o

Non-accelerated Filer o

 

Smaller Reporting Company x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No x

 

Number of shares of $.01 par value common stock outstanding at July 31, 2015 - 2,746,325

(The remainder of this page was intentionally left blank.)

 

 

 




Table of Contents

 

PART 1

 

ITEM 1.  FINANCIAL STATEMENTS

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

 

 

 

June 30

 

DECEMBER 31

 

 

 

2015

 

2014

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash

 

$

68,783

 

$

66,371

 

Accounts Receivable, Less Allowance for Uncollectible Accounts

 

16,656,851

 

17,367,668

 

Inventories

 

20,605,081

 

18,528,418

 

Prepaid Expenses

 

1,308,360

 

816,775

 

Income Taxes Receivable

 

842,106

 

465,236

 

Deferred Income Taxes

 

436,000

 

436,000

 

Total Current Assets

 

39,917,181

 

37,680,468

 

 

 

 

 

 

 

Property and Equipment, Net

 

11,042,807

 

10,888,717

 

Other Assets

 

114,481

 

117,127

 

Total Assets

 

$

51,074,469

 

$

48,686,312

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Current Maturities of Long-Term Debt

 

857,027

 

732,835

 

Accounts Payable

 

11,016,512

 

9,008,426

 

Accrued Payroll and Commissions

 

2,542,976

 

2,896,557

 

Other Accrued Liabilities

 

818,120

 

732,012

 

Total Current Liabilities

 

15,234,635

 

13,369,830

 

 

 

 

 

 

 

Long-Term Liabilities

 

 

 

 

 

Line of Credit

 

8,471,042

 

7,998,184

 

Long-Term Debt, Net of Current Maturities

 

4,819,406

 

4,072,506

 

Deferred Income Taxes

 

149,000

 

149,000

 

Other Long-Term Liabilities

 

132,235

 

268,400

 

Total Long-Term Liabilities

 

13,571,683

 

12,488,090

 

Total Liabilities

 

28,806,318

 

25,857,920

 

Shareholders’ Equity

 

 

 

 

 

Preferred Stock, $1 par value; 1,000,000 Shares Authorized: 250,000 Shares Issued and Outstanding

 

250,000

 

250,000

 

Common Stock - $0.01 par value; 9,000,000 Shares Authorized: 2,746,325 Shares Issued and Outstanding

 

27,463

 

27,430

 

Additional Paid-In Capital

 

15,762,035

 

15,751,160

 

Accumulated Other Comprehensive Loss

 

(62,936

)

(62,936

)

Retained Earnings

 

6,291,589

 

6,862,738

 

Total Shareholders’ Equity

 

22,268,151

 

22,828,392

 

Total Liabilities and Shareholders’ Equity

 

$

51,074,469

 

$

48,686,312

 

 

See Accompanying Condensed Notes to Consolidated Financial Statements

 

3



Table of Contents

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

THREE MONTHS ENDED

 

 

 

JUNE 30

 

 

 

2015

 

2014

 

 

 

 

 

 

 

Net Sales

 

$

26,801,473

 

$

27,408,467

 

 

 

 

 

 

 

Cost of Goods Sold

 

24,371,349

 

24,125,488

 

 

 

 

 

 

 

Gross Profit

 

2,430,124

 

3,282,979

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

Selling Expenses

 

1,310,355

 

1,145,245

 

General and Administrative Expenses

 

1,603,129

 

1,790,557

 

Total Operating Expenses

 

2,913,484

 

2,935,802

 

 

 

 

 

 

 

Income (Loss) From Operations

 

(483,360

)

347,177

 

 

 

 

 

 

 

Other Expense

 

 

 

 

 

Interest Expense

 

(112,002

)

(92,083

)

Miscellaneous Expense, net

 

 

(23,393

)

Total Other Expense

 

(112,002

)

(115,476

)

 

 

 

 

 

 

Income (Loss) Before Income Taxes

 

(595,362

)

231,701

 

 

 

 

 

 

 

Income Tax Expense (Benefit)

 

(217,000

)

(15,000

)

 

 

 

 

 

 

Net Income (Loss)

 

$

(378,362

)

$

246,701

 

 

 

 

 

 

 

Earnings (Loss) Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.14

)

$

0.09

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding - Basic

 

2,746,325

 

2,742,992

 

 

 

 

 

 

 

Diluted

 

$

(0.14

)

$

0.09

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding - Diluted

 

2,746,325

 

2,746,856

 

 

See Accompanying Condensed Notes to Consolidated Financial Statements

 

4



Table of Contents

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

SIX MONTHS ENDED

 

 

 

JUNE 30

 

 

 

2015

 

2014

 

 

 

 

 

 

 

Net Sales

 

$

53,341,095

 

$

53,557,609

 

 

 

 

 

 

 

Cost of Goods Sold

 

48,044,816

 

47,200,695

 

 

 

 

 

 

 

Gross Profit

 

5,296,279

 

6,356,914

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

Selling Expenses

 

2,673,797

 

2,266,146

 

General and Administrative Expenses

 

3,307,443

 

3,507,370

 

Total Operating Expenses

 

5,981,240

 

5,773,516

 

 

 

 

 

 

 

Income (Loss) From Operations

 

(684,961

)

583,398

 

 

 

 

 

 

 

Other Expense

 

 

 

 

 

Interest Expense

 

(207,188

)

(182,063

)

Miscellaneous Expense, net

 

 

(33,477

)

Total Other Expense

 

(207,188

)

(215,540

)

 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) Before Income Taxes

 

(892,149

)

367,858

 

 

 

 

 

 

 

Income Tax Expense (Benefit)

 

(321,000

)

35,000

 

 

 

 

 

 

 

Net Income (Loss)

 

$

(571,149

)

$

332,858

 

 

 

 

 

 

 

Earnings (Loss) Per Common Share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.21

)

$

0.12

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding - Basic

 

2,745,183

 

2,742,992

 

 

 

 

 

 

 

Diluted

 

$

(0.21

)

$

0.12

 

 

 

 

 

 

 

Weighted Average Number of Common Shares Outstanding - Diluted

 

2,745,183

 

2,747,357

 

 

See Accompanying Condensed Notes to Consolidated Financial Statements

 

5



Table of Contents

 

NORTECH SYSTEMS INCORPORATED AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

 

 

SIX MONTHS ENDED

 

 

 

JUNE 30

 

 

 

2015

 

2014

 

Cash Flows From Operating Activities

 

 

 

 

 

Net Income (Loss)

 

$

(571,149

)

$

332,858

 

Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used in) Operating Activities

 

 

 

 

 

Depreciation

 

1,062,951

 

999,234

 

Amortization

 

2,646

 

2,646

 

Compensation on Stock-Based Awards

 

(669

)

14,963

 

Compensation on Equity Appreciation Rights

 

(58,310

)

 

Loss on Disposal of Property and Equipment

 

1,129

 

1,150

 

Deferred Taxes

 

 

51,680

 

Changes in Operating Assets and Liabilities:Changes in Current Operating Items

 

 

 

 

 

Accounts Receivable

 

710,817

 

869,595

 

Inventories

 

(2,076,663

)

(1,963,079

)

Prepaid Expenses

 

(491,585

)

(76,768

)

Income Taxes Receivable

 

(376,870

)

(107,577

)

Accounts Payable

 

1,998,289

 

1,641,621

 

Accrued Payroll and Commissions

 

(353,581

)

(375,076

)

Other Accrued Liabilities

 

16,225

 

(63,288

)

Net Cash Provided by (Used in) Operating Activities

 

(136,770

)

1,327,959

 

Cash Flows from Investing Activities

 

 

 

 

 

Purchases of Property and Equipment

 

(1,214,489

)

(1,128,141

)

Net Cash Used in Investing Activities

 

(1,214,489

)

(1,128,141

)

Cash Flows from Financing Activities

 

 

 

 

 

Borrowings on Line of Credit

 

56,462,817

 

54,795,076

 

Repayments on Line of Credit

 

(55,989,959

)

(54,863,663

)

Proceeds from Long-Term Debt

 

1,352,159

 

230,000

 

Principal Payments on Long-Term Debt

 

(427,752

)

(361,231

)

Debt Issuance Costs

 

(54,838

)

 

Excess Tax Benefit from Stock-Based Compensation

 

911

 

 

Proceeds from Issuance of Common Stock

 

10,333

 

 

Net Cash Provided by Financing Activities

 

1,353,671

 

(199,818

)

Net Increase in Cash

 

2,412

 

 

Cash - Beginning

 

66,371

 

 

Cash - Ending

 

$

68,783

 

$

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

Cash Paid During the Period for Interest

 

$

200,645

 

$

181,981

 

Cash Paid During the Period for Income Taxes

 

 

237,615

 

 

 

 

 

 

 

Supplemental Noncash Investing and Financing Activities

 

 

 

 

 

Capital Expenditures in Accounts Payable

 

19,604

 

25,866

 

 

See Accompanying Condensed Notes to Consolidated Financial Statements

 

6



Table of Contents

 

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 1.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements for the interim periods have been prepared in accordance with Generally Accepted Accounting Principles in the United States of America (GAAP) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission.  Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements, although we believe the disclosures are adequate to make the information presented not misleading.  It is suggested that these consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in our latest shareholders’ annual report on Form 10-K.  The operating results for the interim periods presented are not necessarily indicative of the results expected for the full year or for any other interim period.  In our opinion, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.

 

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  In preparing these consolidated financial statements, we have made our best estimates and judgments of certain amounts included in the consolidated financial statements, giving due consideration to materiality.  Changes in the estimates and assumptions used by us could have a significant impact on our financial results, since actual results could differ from those estimates.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of Nortech Systems Incorporated and its wholly owned subsidiary, Manufacturing Assembly Solutions of Monterrey, Inc.  All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

 

We recognize manufacturing revenue when we ship goods or the goods are received by our customer, when title has passed, all contractual obligations have been satisfied, the price is fixed or determinable and collection of the resulting receivable is reasonably assured. Generally, there are no formal substantive customer acceptance requirements or further obligations related to manufacturing services.  If such requirements or obligations exist, then we recognize the related revenues at the time when such requirements are completed and the obligations are fulfilled.  We also provide engineering services separate from the manufacture of a product. Revenue for engineering services is generally recognized upon completion of the engineering process.  In addition, we have another separate source of revenue that comes from short-term repair services, which are recognized when the repairs are completed and the repaired products are shipped back to the customer.  Our net sales for services were less than 5% of our total sales for all periods presented, and accordingly, are included in net sales in the consolidated statement of operations.  Shipping and handling costs charged to our customers are included in net sales, while the corresponding shipping expenses are included in cost of goods sold.

 

Stock Options

 

Following is the status of all stock options outstanding as of June 30, 2015:

 

7



Table of Contents

 

 

 

Shares

 

Weighted-
Average
Exercise
Price Per
Share

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

Aggregate
Intrinsic Value

 

Outstanding - January 1, 2015

 

181,000

 

$

  6.36

 

 

 

 

 

Granted

 

 

 

 

 

 

 

Exercised

 

(3,333

)

3.20

 

 

 

 

 

Cancelled

 

(37,917

)

5.52

 

 

 

 

 

Outstanding - June 30, 2015

 

139,750

 

$

  6.66

 

2.49

 

$

18,400

 

Exercisable - June 30, 2015

 

134,917

 

$

  6.78

 

2.31

 

$

12,842

 

 

The total intrinsic value of options exercised during the three and six months ended June 30, 2015 was $8,166.  Cash received from options exercised during the three and six months ended June 30, 2015 was $10,333.  There were no options exercised during the three and six months ended June 30, 2014.  There were no stock options granted during the three and six months ended June 30, 2015 and 2014.

 

Total compensation expense (income) related to stock options for the three months ended June 30, 2015 and 2014 was $(4,338) and $7,482, respectively.  Total compensation expense (income) related to stock options for the six months ended June 30, 2015 and 2014 was $(669) and $14,963, respectively.  As of June 30, 2015, there was approximately $5,000 of unrecognized compensation related to unvested option awards that we expect to recognize over a weighted-average period of 0.62 years.

 

Equity Appreciation Rights Plan

 

In November 2010, the Board of Directors approved the adoption of the Nortech Systems Incorporated Equity Appreciation Rights Plan (the “2010 Plan”). The total number of Equity Appreciation Right Units (Units) the Plan can issue shall not exceed an aggregate of 1,000,000 Units as amended and restated on March 11, 2015 and approved by the shareholders on May 6, 2015.  The 2010 Plan provides that Units issued shall fully vest three years from the base date as defined in the agreement unless terminated earlier. Units give the holder a right to receive a cash payment equal to the appreciation in book value per share of common stock from the base date, as defined, to the redemption date. Unit redemption payments under this plan shall be paid in cash within 90 days after we determine the value as of the redemption date.

 

During the six months ended June 30, 2015, we granted 57,500 Units with a base date of January 1, 2015 and vesting dates through January 1, 2018.

 

Total compensation expense (income) related to the vested outstanding Units based on the estimated appreciation over their remaining terms was approximately $(46,000) and $38,000 for the three months ended June 30, 2015 and 2014, respectively and $(58,000) and $80,000 for the

 

8



Table of Contents

 

six months ended June 30, 2015 and 2014, respectively.  The income for the three and six months ended June 30, 2015 was the result of a change in the assumption of the appreciation of book value per share of common stock.

 

As of June 30, 2015 and December 31, 2014, approximately $154,000 and $259,000 is accrued under this plan, respectively.  As of June 30, 2015, approximately $78,000 of this balance is included in Other Accrued Liabilities and the remaining $76,000 balance was included in Other Long-term Liabilities.  As of December 31, 2014, approximately $47,000 of this balance is included in Other Accrued Liabilites and the remaining $212,000 was included in Other Long-term Liabilities.

 

Earnings per Common Share

 

For the three and six months ended June 30, 2015, the effect of all stock options is antidilutive due to the net loss incurred and, therefore, were not included in the computation of per-share amounts.  For the three and six months ended June 30, 2015, stock options of 123,750 and 126,375, respectively, were excluded because their inclusion would be antidilutive.

 

For both the three and six months ended June 30, 2014, 26,750 stock options were included in the computation of diluted per share amounts as their impact was dilutive.  For the three and six months ended June 30, 2014, stock options of 189,250 and 169,250, respectively were excluded because their inclusion would be antidilutive.

 

Segment Reporting Information

 

All of our operations fall under the Contract Manufacturing segment within the Electronic Manufacturing Services industry.  We strategically direct production between our various manufacturing facilities based on a number of considerations to best meet our customers’ requirements.  We share resources for sales, marketing, engineering, supply chain, information services, human resources, payroll, and all corporate accounting functions.  Consolidated financial information is available that is evaluated regularly by the chief operating decision maker in assessing performance and allocating resources.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

We grant credit to customers in the normal course of business.  Accounts receivable are unsecured and are presented net of an allowance for doubtful accounts.  The allowance for doubtful accounts was $130,000 and $137,000 at June 30, 2015 and December 31, 2014, respectively.  We determine our allowance by considering a number of factors, including the length of time accounts receivable are past due, our previous loss history, the customers’ current ability to pay their obligations to us, and the condition of the general economy and the industry as a whole.  We write-off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the allowance for uncollectible accounts.

 

Inventories

 

Inventories are stated at the lower of cost (first-in, first-out method) or market (based on the lower of replacement cost or net realizable value).  Costs include material, labor, and overhead

 

9



Table of Contents

 

required in the warehousing and production of our products.  Inventory reserves are maintained for the estimated value of the inventories that may have a lower value than stated or quantities in excess of future production needs.

 

Inventories are as follows:

 

 

 

June 30

 

December 31

 

 

 

2015

 

2014

 

 

 

 

 

 

 

Raw Materials

 

$

14,686,768

 

$

12,745,623

 

Work in Process

 

3,654,868

 

3,653,670

 

Finished Goods

 

3,026,931

 

2,861,373

 

Reserve

 

(763,486

)

(732,248

)

 

 

 

 

 

 

Total

 

$

20,605,081

 

$

18,528,418

 

 

Impairment Analysis

 

We evaluate long-lived assets, primarily property and equipment, as well as the related depreciation periods, whenever current events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable.  Recoverability for assets to be held and used is based on our projection of the undiscounted future operating cash flows of the underlying assets.  To the extent such projections indicate that future undiscounted cash flows are not sufficient to recover the carrying amounts of related assets, a charge might be required to reduce the carrying amount to equal estimated fair value.

 

Recent Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This standard outlines a single comprehensive model for companies to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that revenue is recognized when a customer obtains control of a good or service. A customer obtains control when it has the ability to direct the use of and obtain the benefits from the good or service. Transfer of control is not the same as transfer of risks and rewards, as it is considered in current guidance.  In the first quarter of 2015, the FASB approved a deferral of the effective date to January 1, 2018.  Upon adoption in 2018, the company will record an adjustment to retained earnings as of the beginning of the year of initial application, which can be either the earliest comparative period presented, with all periods presented under the new rules, or January 1, 2018, without restating prior periods presented.  Management has not yet determined which transition reporting option it will apply.

 

In April 2014, the FASB issued ASU No. 2015-03, Interest — Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Cost. This ASU requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct

 

10



Table of Contents

 

deduction from the carrying amount of that debt liability, consistent with debt discounts.  The recognition and measurement guidance for debt issuance costs is not affected by the new guidance.  The updated standard will be effective for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years.  All entities have the option of adopting the new requirements as of an earlier date for financial statements that have not been previously issued.  The guidance should be adopted on a retrospective basis, wherein the balance sheet of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance.  The Company has adopted ASU 2015-03 and presented its debt issuance costs as a component of long term debt.

 

NOTE 2. CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS

 

Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and accounts receivable.  With regard to cash, we maintain our excess cash balances in checking accounts at two high-credit quality financial institutions.  These accounts may at times exceed federally insured limits.  We grant credit to customers in the normal course of business and do not require collateral on our accounts receivable.

 

Our largest customer, General Electric, has two divisions that collectively account for more than 10% of net sales for the three and six months ended June 30, 2015 and 2014:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

 

2015

 

2014

 

2015

 

2014

 

GE Healthcare

 

17

%

24

%

17

%

24

%

GE Transportation

 

8

 

6

 

8

 

5

 

Total General Electric

 

25

%

30

%

25

%

29

%

 

Combined accounts receivable from both divisions represented 18% and 19% of total accounts receivable at June 30, 2015 and December 31, 2014, respectively.

 

Export sales represented 13% and 14% of net sales for the three months ended June 30, 2015 and 2014, respectively.  Export sales represented 12% and 13% of net sales for the six months ended June 30, 2015 and 2014, respectively.

 

NOTE 3. FINANCING ARRANGEMENTS

 

We have a credit agreement with Wells Fargo Bank (WFB) which was most recently amended on May 7, 2015 and provides for a line of credit arrangement of $15.0 million that expires, if not renewed, on May 31, 2018.  The credit arrangement also has a $1.8 million real estate term note outstanding with a maturity date of March 31, 2027, an additional $1.7 million real estate term note outstanding that is due, if not renewed, on December 31, 2027, an equipment loan for $2.7 million and a new term loan facility of up to $1.0 million for capital expenditures, both with

 

11



Table of Contents

 

maturity dates of May 31, 2018.  We incurred $54,838 of related costs and fees associated with the amended credit agreement.  These fees were capitalized as a debt discount and are being amortized as interest expense over the term of the debt agreement.  As of June 30, 2015, we have not borrowed against the $1.0 million capital term note.

 

Long-term debt at June 30, 2015 and December 31, 2014 consisted of the following:

 

 

 

June 30

 

December 31

 

 

 

2015

 

2014

 

Real Estate Term Loan 1, interest at three month LIBOR + 2.75%, due in installments through March 31, 2027

 

$

1,356,228

 

$

1,415,461

 

Real Estate Term Loan 2, interest at three month LIBOR + 2.75%, due in installments through December 31, 2027

 

1,404,300

 

1,460,100

 

Equipment loan, interest at three month LIBOR + 2.75%, due January 31, 2016

 

 

102,917

 

Equipment loan, interest at three month LIBOR + 2.75%, due May 31, 2018

 

 

1,117,863

 

Equipment loan, interest at three month LIBOR + 2.75%, due May 31, 2018

 

 

349,000

 

Equipment loan, interest at three month LIBOR + 2.75%, due May 31, 2018

 

2,689,220

 

 

Blue Earth Bond, which bears a variable interest rate, due in installments through June 30, 2021

 

280,000

 

360,000

 

Debt Issuance Costs

 

(53,315

)

 

Total debt

 

5,676,433

 

4,805,341

 

Less current maturities

 

857,027

 

732,835

 

Long-term debt

 

$

4,819,406

 

$

4,072,506

 

 

Under the credit agreement, both the line of credit and real estate term notes are subject to variations in the LIBOR rate.  Our line of credit bears interest at three-month LIBOR + 2.25% (approximately 2.5% at June 30, 2015) while our real estate term notes bear interest at three-month LIBOR + 2.75% (approximately 3.0% at June 30, 2015).  The weighted-average interest rate on our line of credit was 2.8% for the three and six months ended June 30, 2015.  We had borrowing on our line of credit of $8,471,042 and $7,998,184 outstanding as of June 30, 2015 and December 31, 2014, respectively.  The line of credit requires a lock box arrangement; however there are no acceleration clauses that would accelerate the maturity of our outstanding borrowings.

 

The credit agreement contains certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures.

 

The availability under the line is subject to borrowing base requirements, and advances are at the discretion of the lender.  At June 30, 2015, we have net unused availability under our line of credit of approximately $5.5 million.  The line is secured by substantially all of our assets.

 

NOTE 4.  INCOME TAXES

 

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate.  As the year progresses, we

 

12



Table of Contents

 

refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction.  Our effective tax rate for the three and six months ended June 30, 2015 was 36%. Our effective tax rate for the three and six months ended June 30, 2014 was (6%) and 10%, respectively. The lower effective tax rate for 2014 was the result of a favorable audit settlement with the Minnesota Department of Revenue which included the acceptance of our research and development credits of $100,000 which were previously reserved for as an uncertain position.  The effective tax rate for the year ended December 31, 2015 is expected to be 36% compared to 8.4% for the year ended December 31, 2014.  The decreased tax rate in 2014 was largely due to the result of the favorable audit settlement with the Minnesota Department of Revenue.

 

The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three and six months ended June 30, 2015 and 2014 are as follows:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

 

2015

 

2014

 

2015

 

2014

 

Statutory federal tax provision (benefit)

 

$

(188,000

)

$

79,000

 

$

(270,000

)

$

130,000

 

State income taxes (benefits)

 

(16,000

)

12,000

 

(26,000

)

19,000

 

Income tax credits

 

(12,000

)

(6,000

)

(25,000

)

(14,000

)

Change in uncertain tax positions

 

 

 

(100,000

)

 

 

(100,000

)

Other

 

(1,000

)

 

 

 

 

Income tax expense (benefit)

 

$

(217,000

)

$

(15,000

)

$

(321,000

)

$

35,000

 

 

At June 30, 2015, we had $56,500 of net uncertain tax benefit positions remaining in other long-term liabilities related to research and development credits that would increase our effective income tax rate if recognized.  At December 31, 2014, we had $56,000 of net uncertain tax benefit positions recorded in other long-term liabilities that would reduce our effective income tax rate if recognized.

 

NOTE 5.  COMMITMENTS AND CONTINGENCIES

 

We have various operating leases for production and office equipment, office space, and buildings under non-cancelable lease agreements expiring on various dates through 2022.

 

On April 1, 2015, we entered into an 89 month lease for approximately 19,000 square feet of space in Maple Grove, Minnesota for our new corporate headquarters.  Annual rent payments during the lease term will increase from approximately $139,000 to $165,000.  In addition to this rent obligation, we will also be responsible for certain costs, among other things, operating expenses, taxes, and insurance costs.

 

Rent expense for the three months ended June 30, 2015 and 2014 amounted to approximately $183,000 and $166,000, respectively.  Rent expense for the six months ended June 30, 2015 and 2014 amounted to approximately $363,000 and $335,000, respectively.

 

13



Table of Contents

 

Approximate future minimum lease payments under non-cancelable leases subsequent to June 30, 2015 are as follows:

 

Years Ending

 

 

 

December 31,

 

Amount

 

2015

 

$

376,975

 

2016

 

439,902

 

2017

 

393,556

 

2018

 

397,161

 

2019

 

400,229

 

Thereafter

 

535,883

 

Total

 

$

2,543,706

 

 

NOTE 6.  SUBSEQUENT EVENT (UNAUDITED)

 

On July 1, 2015, we completed the acquisition of substantially all of the assets of Devicix, LLC upon the terms and conditions contained in an Asset Purchase Agreement entered into on June 17, 2015, with Devicix.

 

Devicix is an innovative medical product design and engineering firm with a proven track record of helping clients move from concept to production. The addition of Devicix will enhance and broaden our capabilities for complete design, manufacturing and service, particularly for regulated medical devices.

 

The purchase price of $5.3 million was funded by net cash payments of $2.0 million from our operating line of credit at closing, $0.5 million of customer deposits with the majority of the work to be completed by 2015 year end, assumed working capital deficit of $0.5 million and two promissory notes payable to the seller in the aggregate principal amounts of $1.0 million and $1.3 million.  The $1.0 million promissory note has a four-year term, bearing interest at 4% per annum and is subject to offsets.  The $1.3 million promissory note has a four year term and bears interest at 4% per annum and is not subject to offset.

 

The asset purchase agreement also includes an earnout payable within 90 days of the completion of each of the first four 12-month periods after July 1, 2015.  The earnout will be equal to 15% of eligible engineering revenue over a $6,000,000 threshold and 3% of eligible production revenue generated from Devicix customers.  The maximum dollar amount of earnout payments under the Asset Purchase Agreement is $2,500,000.

 

14



Table of Contents

 

Due to the timing of the acquisition we have not yet completed our valuation of the fair value of acquired assets and assumed liabilities nor the fair value of the contingent consideration, we expect this to be completed in the third quarter.  We expect that the amortization of any goodwill will be deductible for tax purposes.

 

ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview:

 

We are a Maple Grove, Minnesota based full-service electronics manufacturing services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries.  We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.  All of our facilities are certified to one or more of the ISO standards, including 9001 and 13485, with most having additional certifications based on the needs of the customers they serve.

 

Summary of Results:

 

Our second quarter results were again impacted by customer and market mix and further investment costs associated with growth initiatives in Mexico and Asia. Our opportunity for growth in China is due to our existing customers’ need to serve Asian customers with regional manufacturing.

 

Immediate actions are being implemented to mitigate the current margin trends with increased focus on lean initiatives by work order and improvements to our NPI (new product introduction) process to reduce ramp up costs and time to market.

 

On a long-term basis we continue to consider alternatives to reduce excess capacity and possible divestitures of non-profitable businesses and we are committed to execute on our growth initiatives.

 

Revenue in the second quarter of 2015 was up sequentially 1% compared to our first quarter on mixed results and down 2% compared to the second quarter of 2014. Our larger global customers’ demand continues to be impacted by market and economic issues related to the strong US dollar, the depressed oil and gas industry and challenging global economies in China, Asia Pacific and Europe. Their shortfalls are being offset by new business and growth from both our industrial and defense customers.

 

15



Table of Contents

 

Our gross profit percentage for the three months ended June 30, 2015 was 9.1% compared to 12.0% for the three months ended June 30, 2014.  Our gross profit percentage for the six months ended June 30, 2015 was 9.9% compared to 11.9% for the six months ended June 30, 2014.  In 2015 gross profit percentage is being negatively affected by customer mix, with decreased revenue from our higher margin medical customers, partially offset by revenue from lower margin industrial customers.

 

Operating profits continue to be impacted by the mix of customer orders and our continued investments in long term growth strategies. Industrial customer margins historically have experienced lower than our average margins while medical customer margins have been higher than our average.  Defense margins have been depressed due to DOD budget constraints and increased competition for the programs that are being funded.  Margin loss accounts for  more than half of the operating loss, while investments in China/Asia expansion, Mexico PCB assembly operation startup costs and increases in selling expense to maintain current business development activities account for the other portion of the loss.

 

Net loss for the three months ended June 30, 2015 was $378,000 or $0.14 per diluted common share, compared to net income for the three months ended June 30, 2014 of $247,000 or $0.09 per diluted common share.  Net loss for the first six months of 2015 was approximately $571,000 or $0.21 per diluted common share, compared to net income of approximately $333,000 or $0.12 per diluted common share for the same period in 2014.

 

Cash used in operating activities for the first six months of 2015 was approximately $137,000.  Cash used resulted from increased inventories and the operating loss partially offset by the noncash addback of depreciation and the timing of working capital changes.

 

Results of Operations:

 

The following table presents statements of operations data as percentages of total net sales for the periods indicated:

 

16



Table of Contents

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

 

2015

 

2014

 

2015

 

2014

 

Net Sales

 

100.0

%

100.0

%

100.0

%

100.0

%

Cost of Goods Sold

 

90.9

 

88.0

 

90.1

 

88.1

 

Gross Profit

 

9.1

 

12.0

 

9.9

 

11.9

 

 

 

 

 

 

 

 

 

 

 

Selling Expenses

 

4.9

 

4.2

 

5.0

 

4.2

 

General and Administrative Expenses

 

6.0

 

6.5

 

6.2

 

6.6

 

Income (Loss) from Operations

 

(1.8

)

1.3

 

(1.3

)

1.1

 

 

 

 

 

 

 

 

 

 

 

Other Expenses, Net

 

(0.4

)

(0.4

)

(0.4

)

(0.4

)

Income (Loss)Before Income Taxes

 

(2.2

)

0.9

 

(1.7

)

0.7

 

 

 

 

 

 

 

 

 

 

 

Income Tax Expense (Benefit)

 

(0.8

)

0.0

 

(0.6

)

0.1

 

Net Income (Loss)

 

(1.4

)%

0.9

%

(1.1

)%

0.6

%

 

Net Sales:

 

We reported net sales of $26.8 million and $27.4 million for the three months ended June 30, 2015 and 2014, respectively.  We reported net sales of $53.3 million and $53.6 million for the six months ended June 30, 2015 and 2014, respectively.

 

Net sales by our major EMS industry markets for the three and six month periods ended June 30, 2015 and 2014 were as follows:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

 

2015

 

2014

 

%

 

2015

 

2014

 

%

 

(in thousands)

 

$

 

$

 

Change `

 

$

 

$

 

Change

 

Aerospace and Defense

 

3,639

 

3,633

 

0

 

6,691

 

8,032

 

(17

)

Medical

 

9,027

 

10,787

 

(16

)

18,192

 

20,645

 

(12

)

Industrial

 

14,136

 

12,989

 

9

 

28,458

 

24,881

 

14

 

Total Sales

 

26,802

 

27,409

 

(2

)

53,341

 

53,558

 

(0

)

 

Backlog:

 

Our 90-day order backlog as of June 30, 2015 increased 6% to approximately $19.4 million, compared to approximately $18.3 million at the beginning of the quarter.  Backlog for our industrial and defense customers have increased over prior year and prior quarter.  Backlog for our major medical customers is being impacted globally by the strong U. S. dollar and weak global economy.  Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter.

 

90 Day backlog by our major EMS industry markets are as follows:

 

17



Table of Contents

 

 

 

Backlog as of the Quarter Ended

 

 

 

June 30

 

March 31

 

June 30

 

(in thousands)

 

2015

 

2015

 

2014

 

 

 

 

 

 

 

 

 

Aerospace and Defense

 

$

4,307

 

$

3,834

 

$

3,647

 

Medical

 

6,143

 

6,129

 

8,638

 

Industrial

 

8,990

 

8,316

 

6,917

 

Total Backlog

 

$

19,440

 

$

18,279

 

$

19,202

 

 

Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.

 

Gross Profit:

 

Gross profit as a percent of net sales for the three months ended June 30, 2015 and 2014 was 9.1% and 12.0%, respectively.  Gross profit as a percent of net sales for the six months ended June 30, 2015 and 2014 was 9.9% and 11.9%, respectively.  Gross profit percentage in 2015 is being negatively affected by customer mix, with decreased revenue from our higher margin medical customers, partially offset by revenue from lower margin industrial customers.

 

Selling Expense:

 

Selling expense for the three months ended June 30, 2015 and 2014 was $1.3 million or 4.9% of sales and $1.1 million or 4.2% of sales, respectively.  Selling expense for the six months ended June 30, 2015 and 2014 was $2.7 million or 5.0% of sales and $2.3 million or 4.2% of sales, respectively.  The increase in selling expense is related to increased business development activities needed to support growth initiatives and add manufacturing capabilities in China.

 

General and Administrative Expense:

 

General and administrative expenses for the three months ended June 30, 2015 and 2014 were $1.6 million or 6.0% of sales and $1.8 million or 6.5% of sales, respectively.  General and administrative expenses for the six months ended June 30, 2015 and 2014 were $3.3 million or 6.2% of sales and $3.5 million or 6.6% of sales, respectively.  The decrease in general and administrative expense was due to cost reductions implemented during first and second quarter to match current customer demand.

 

Income Taxes:

 

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate.  As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax

 

18



Table of Contents

 

jurisdiction.  Our effective tax rate for the three and six months ended June 30, 2015 was 36%. Our effective tax rate for the three and six months ended June 30, 2014 was (6%) and 10%, respectively. The lower effective tax rate for 2014 was the result of a favorable audit settlement with the Minnesota Department of Revenue which included the acceptance of our research and development credits of $100,000 which were previously reserved for as an uncertain position.  The effective tax rate for the year ended December 31, 2015 is expected to be 36% compared to 8.4% for the year ended December 31, 2014.  The decreased tax rate in 2014 was largely due to the result of the favorable audit settlement with the Minnesota Department of Revenue.

 

The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three and six months ended June 30, 2015 and 2014 are as follows:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30

 

June 30

 

 

 

2015

 

2014

 

2015

 

2014

 

Statutory federal tax provision (benefit)

 

$

(188,000

)

$

79,000

 

$

(270,000

)

$

130,000

 

State income taxes (benefits)

 

(16,000

)

12,000

 

(26,000

)

19,000

 

Income tax credits

 

(12,000

)

(6,000

)

(25,000

)

(14,000

)

Change in uncertain tax positions

 

 

 

(100,000

)

 

 

(100,000

)

Other

 

(1,000

)

 

 

 

 

Income tax expense (benefit)

 

$

(217,000

)

$

(15,000

)

$

(321,000

)

$

35,000

 

 

Liquidity and Capital Resources:

 

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and an operating line of credit through WFB.  We also have real estate and equipment term loans.  On May 7, 2015, we entered into an amendment to our credit agreement with WFB providing for a $15.0 million line of credit through May 31, 2018, which is a $1.5 million increase from the previous line. The amendment also provides a new equipment term note in the amount of approximately $1.0 million, which is in addition to the existing equipment term notes in the aggregate amount of approximately $2.7 million, all of which equipment term notes having a maturity date of May 31, 2018. In addition, the amendment provides for a new term loan of up to $1.0 million for capital expenditures to be made prior to May 31, 2018 with a maturity date of May 31, 2018. The amendment did not amend any terms of the two real estate term loans outstanding in an aggregate amount of approximately $3.5 million under the existing agreement.

 

Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates.  The line of credit, real estate term notes, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures.  The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender.  The line of credit is secured by substantially all of our assets.

 

On June 30, 2015, we had outstanding advances of $8.5 million under the line of credit and unused availability of $5.5 million supported by our borrowing base. A cash payment on July 1, 2015 for a portion of the purchase price of the Devicix acquisition reduced our availability by $2.0 million.  We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs.  Our working capital was $24.7 million and $24.3 million as of June 30, 2015 and December 31, 2014, respectively.

 

Our credit agreement with requires us to maintain a minimum fixed charge coverage ratio of not less than 1.10 to 1.00 for the trailing twelve month period ending January 31, 2015, up to and including September 30, 2015, and 1.20 to 1.00 for each period therafter.

 

19



Table of Contents

 

The minimum fixed charge coverage ratio at June 30, 2015 was 1.71 to 1.00.  We believe our performance will be sufficient to comply with this covenant going forward.

 

Net cash used in operating activities for the six months ended June 30, 2015 was $0.1 million.  Cash used was the result of the first quarter loss and increased inventories partially offset by the noncash addback of depreciation and the timing of accounts payable payments and accounts receivable collections.

 

Net cash used in investing activities of $1.2 million for the six months ended June 30, 2015 is comprised of property and equipment purchases to support the business.

 

On July 1, 2015, we completed the acquisition of substantially all of the assets of Devicix, LLC upon the terms and conditions contained in an Asset Purchase Agreement entered into on June 17, 2015, with Devicix. The purchase price of $5.3 million was funded by net cash payments of $2.0 million from our operating line of credit at closing, $0.5 million of customer deposits with the majority of the work to be completed by 2015 year end, assumed working capital deficit of $0.5 million and two promissory notes with the seller in the aggregate principal amounts of $1.0 million and $1.3 million. The $1.0 million promissory note has a four-year term, bearing interest at 4% per annum and is subject to offsets. The $1.3 million promissory note has a four year term and bears interest at 4% per annum and is not subject to offset. The asset purchase agreement also includes an earnout payable within 90 days of the completion of each of the first four 12-month periods after July 1, 2015. The earnout will be equal to 15% of eligible engineering revenue over a $6,000,000 threshold and 3% of eligible production revenue generated from Devicix customers. The maximum dollar amount of earnout payments under the Asset Purchase Agreement is $2,500,000.

 

Off - Balance Sheet Arrangements:

 

We have not engaged in any off - balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.

 

Critical Accounting Policies and Estimates:

 

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2014.  There have been no significant changes in these critical accounting policies since December 31, 2014.  Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates.  Such judgments are subject to an inherent degree of uncertainty.  These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate.  Actual results could differ from these estimates.

 

Recent Accounting Pronouncements

 

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). This standard outlines a single comprehensive model for companies to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The core principle of the revenue model is that revenue is recognized when a customer obtains control of a good or service. A customer obtains control when it has the ability to direct the use of and obtain the benefits from the good or service. Transfer of control is not the same as transfer of risks and rewards, as it is considered in current guidance.  In the first quarter of 2015, the FASB approved a deferral of the effective date to January 1, 2018.  Upon adoption in 2018, the company will record an adjustment to retained earnings as of the beginning of the year of initial application, which can be either the earliest comparative period presented, with all periods presented under the new rules, or January 1, 2018, without restating prior periods presented.  Management has not yet determined which transition reporting option it will apply.

 

Forward-Looking Statements:

 

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.  Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or

 

20



Table of Contents

 

outcomes.  Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate.  Forward-looking statements involve a number of risks and uncertainties.  Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

 

·                  Volatility in the marketplace which may affect market supply and demand for our products;

·                  Increased competition;

·                  Changes in the reliability and efficiency of operating facilities or those of third parties;

·                  Risks related to availability of labor;

·                  Increase in certain raw material costs such as copper;

·                  Commodity and energy cost instability;

·                  General economic, financial and business conditions that could affect our financial condition and results of operations; and

·                  Availability of raw material components.

 

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us.  Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements.  All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements.  We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

 

Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2014.

 

ITEM 4.   CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures:

 

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act).  These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief  Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and

 

21



Table of Contents

 

procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting:

 

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II

 

ITEM 1.   LEGAL PROCEEDINGS

 

We are subject to various legal proceedings and claims that arise in the ordinary course of business.

 

ITEM 6. EXHIBITS

 

Exhibits

 

 

 

 

 

4.1

 

Nortech Systems lncorporated Restated Equity Appreciation Rights Plan (incorporated herein by reference to Appendix A of the Company's definitive Proxy Statement filed March 24, 2015).

 

 

 

10.1*

 

Asset Purchase Agreement dated as of June 17, 2015 among the Company, Devicix, LLC, and Peter M. DeLange.

 

 

 

10.2

 

Seventh Amendment to Third Amended and Restated Credit and Security Agreement effective as of May 7, 2015 between the Company and Wells Fargo Bank, National Association (incorporated herein by reference to Exhibit 10.1 of the Company’s Form 8-K filed May 7, 2015).

 

 

 

31.1*

 

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

 

31.2*

 

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended.

 

 

 

32*

 

Certification of the Chief Executive Officer and Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

101*

 

Financial statements from the quarterly report on Form 10-Q for the quarter ended June 30, 2015, formatted in XBRL: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Income, (iii) Consolidated Statements of Cash Flows, and (iv) the Condensed Notes to Consolidated Financial Statements.

 


 

 

* Filed Herewith

 

22



Table of Contents

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Nortech Systems Incorporated and Subsidiary

 

 

Date: August 5, 2015

by

/s/ Richard G. Wasielewski

 

 

 

Richard G. Wasielewski

 

Chief Executive Officer and President

 

Nortech Systems Inc.

 

 

Date: August 5, 2015

by

/s/ Paula M. Graff

 

 

 

Paula M. Graff

 

Vice President and Chief Financial Officer

 

Nortech Systems Inc.

 

23